Informed consent: defining limits through therapeutic parameters.
D035843:Biomedical Research; D002140:California; D002460:Cell Line; D030881:Disclosure; D004467:Economics; D013502:General Surgery; D006679:HIV Seropositivity; D006805:Human Experimentation; D006801:Humans; D007049:Iatrogenic Disease; D007258:Informed Consent; D007603:Jurisprudence; D016365:Liability, Legal; D008396:Maryland; D009026:Mortality; D009042:Motivation; D009369:Neoplasms; D010067:Ownership; D010330:Patents as Topic; D005791:Patient Care; D010361:Patients; D010817:Physician-Patient Relations; D010820:Physicians; D011379:Prognosis; D012015:Reference Standards; D012106:Research; D012108:Research Personnel; D035842:Research Subjects; D014019:Tissue Donors; D009927:Tissue and Organ Procurement; D016896:Treatment Outcome; D014342:Truth Disclosure; D014481:United States
Arato v. Avedon; Faya v. Almaraz; Legal Approach; Moore v. Regents of the University of California; Professional Patient Relationship